M

MoonLake Immunotherapeutics
NASDAQ:MLTX

Watchlist Manager
MoonLake Immunotherapeutics
NASDAQ:MLTX
Watchlist
Price: 51.06 USD -1.6%
Market Cap: 3.3B USD
Have any thoughts about
MoonLake Immunotherapeutics?
Write Note

MoonLake Immunotherapeutics
Total Current Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

MoonLake Immunotherapeutics
Total Current Liabilities Peer Comparison

Comparables:
ADCT
ACIU
CRSP
MOLN
XLS

Competitive Total Current Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Total Current Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
M
MoonLake Immunotherapeutics
NASDAQ:MLTX
Total Current Liabilities
$10m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
ADC Therapeutics SA
NYSE:ADCT
Total Current Liabilities
$67.7m
CAGR 3-Years
19%
CAGR 5-Years
25%
CAGR 10-Years
N/A
AC Immune SA
NASDAQ:ACIU
Total Current Liabilities
CHf100.5m
CAGR 3-Years
104%
CAGR 5-Years
50%
CAGR 10-Years
N/A
CRISPR Therapeutics AG
NASDAQ:CRSP
Total Current Liabilities
$89.8m
CAGR 3-Years
-2%
CAGR 5-Years
2%
CAGR 10-Years
N/A
Molecular Partners AG
SIX:MOLN
Total Current Liabilities
CHf11.4m
CAGR 3-Years
-42%
CAGR 5-Years
-20%
CAGR 10-Years
N/A
Xlife Sciences AG
SIX:XLS
Total Current Liabilities
CHf5.8m
CAGR 3-Years
23%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is MoonLake Immunotherapeutics's Total Current Liabilities?
Total Current Liabilities
10m USD

Based on the financial report for Dec 31, 2023, MoonLake Immunotherapeutics's Total Current Liabilities amounts to 10m USD.

What is MoonLake Immunotherapeutics's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 1Y
30%

Over the last year, the Total Current Liabilities growth was 30%.

Back to Top